>PROKKA_00001 hypothetical protein
MKSKEVLELLQITRPTLTKYVREGIIKTTTLPNGRYDYDKDSVYKLFNKGVDRKTYIYAR
VSTNKQKADLENQINMLKQFCFSNGYCISKVFSDVASGISFEKRKEFFNMLDDIVSGKVE
RVVITYKDRLSRVGFELFFHLFKKYNCEIVVMSEIGSKKLDSEEIFEEIISLLHCYSMKL
YSKRKGQKIKEILTENEVNEDD*
>PROKKA_00002 hypothetical protein
MNEIIVKGMFKMNKTKIKSIIVSIVLVSSLFIVSGCNLLENEYKQLQEHFKGRNAIITTY
DKESKPLDRIEGKSISISLDDKFKEQDEKGETIKKSSVLNMDS*
>PROKKA_00003 Adenine specific DNA methylase Mod
MEGGGQTDRYPTTIIDIPYNTIKIKDQKLVELYEYLIKTYTNEGGTVLDFTAGSCVLAEA
CINTNRNYICIEKEKKHCNEAKERIKLHLEKGKQLKII*
>PROKKA_00004 hypothetical protein
LLEVNNIYLGNCLEIMKKIDDKSIDMVLSDLPFGMTNNEWDKAIPFEPMWQEINRIAKDN
ASIALMAAGVFTSELVVSNKKYYRYSWIWKPKEKSNFLNANRMPLRQHIDIPIFYKRLPV
YNP*
>PROKKA_00005 hypothetical protein
MFWFDKENKDVIFMDNRELEDTLCDGRKLIIEPDILGDFRNIPYKDNTFKLVVFDPPHLI
KAGENSWLAKKYGKLNSDWPIDIRQGFNECMRVLDKHGILIFKWNEEQIKIKDILKVIDY
KPLLGNKRAKTHWLVFMKK*
>PROKKA_00006 hypothetical protein
MKKYELVIENPTDAFILDKEKNKIIALCNTKRPDLEFNELKNLIEKVNKNTKQLFQLGDI
AYMIDEDYRFFESEVCSIELKNGKYYYNTHDCDFEDKDIGDWVFESEMYRELHLEAMM*
>PROKKA_00007 hypothetical protein
MKVKLIGENKTEVQFSNKKEGNLINQLKFFGAVPTKESSLYTYFQFNGDIQATMDNFGFR
I*
>PROKKA_00008 hypothetical protein
MIKTKLFTGVTVLEAVYDYQDFIKRNQNLEIISVNILKDNFVLLTYKMFKEDIKW*
>PROKKA_00009 hypothetical protein
MISIKRKDEIWNAIYAEPCLLDFNTLNTEELSFAIGIIISAGSRNSFKEDHFNKEQLKFL
KKVFKELLKL*
>PROKKA_00010 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNNNIIMMEPPFARGMGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVNDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIISPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKNMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFSDDLSKNERIAYNTQNN
YIDNDFSINELILDTDLISKIELPSENTESLTDFNVYVPEYKKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVDD
FVIEANKSSTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIETINSALTKRDEKWIDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYKYNIYSEKERSNINIDFNDVNSKLNEGINQAIDNINNFINECSV
SYLMKKMIPLAVEKLLDFDNTLRKNLLNYIDENKLYLIGSAEYEKSKVDKYLKTSIPFDL
STYTNNTILIEIFNKYNSDILNNIILNLRYRDNKLIDLSGYGAKVEVYDGVKLNDKNQFK
LTSSANSKIRVIQNQNIIFNSMFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNS
GWKISIRGNMIIWTLIDINGKIKSVFFEYSIKEDISEYINRWFFVTITNNSDNAKIYING
KLESHIDIRDIREVIANDEIIFKLDGNIDRTQFIWMKYFSIFNTELSQSNIEEIYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYIYKYFKKEEEKLFLAPISD
SDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFKEYKDYFCIS
KWYLKEVKRKPYNSKLGCNWQFIPKDEGWTE*
>PROKKA_00011 Botulinum neurotoxin type A precursor
MCVEINLGGWLDMNINDNLSINSPVDNKNVVVVRARKTDTVFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDEFYIDPAIELIKCLIK
SLYFLYGIKPSDDLVIPYRLRSELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFTDNYF
SNAKKVFEDHRNIYETEIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFSIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLSLSDRNQDIINKPEEIINLLNG
NNVSLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNIGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNEKFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKKYYLWLREIFRNYSFDITATQEINTDCGINKV
VTWFGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPIIEIYGIPNDMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LFKADISMDKLNLMNLATEKTFIDLSNESQIAINNINDFLNKSAICVFDTNIYPKFISFM
EQCINSVNSNVTAFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQSIKDLITSETDLIK
EEKESDYNLFLFTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPDESVSF
SNKAFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFENNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSNTISLVNEN
NPIYIEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFPENSLY
EVTENNNIYLSIKDTNNLNIQGAKFKLINIDANKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSKDTAKRIIFNNDIFRPNCLTFAYNNKYLSLSLRDRNYNWMICNNNDNIPKA
AHLWALKGI*
>PROKKA_00012 transcriptional regulator BotR, P-21
MNKLFLQIEMLKNDNEEFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIADKKLSLIANSYSSYSEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALERLEPILKKLINM*
>PROKKA_00013 hypothetical protein
MEHYSVIQNSLNDKIVTISCKADTNLFFYQVAGNVSLFQQTRNYLERWRLIYDSNKAAYK
IKSMDIHNTNLVLTWNAPTHNISTQQDSNADNQYWLLLKDIGNNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSNYIKFIIEDYIISDLNNFTCKISPILDRNKVVQQVATTNLNVNLY
TWDYGRNQKWTIRYNEEKAAYQFFNTILSNGVLTWIFSNGNTVRVSSSNDQNNDAQYWLI
NPVSDTDETYTITNLRDTTKALDLYNSQTANGTAIQVFNSNGGDNQKWNIRNP*
>PROKKA_00014 HA 17 kDa subunit
MSVERTFLPNGNYNIKSIFSGSLYLNPVSKSLTFSNESSANNQKWNVEYMAENRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMFKLEKI*
>PROKKA_00015 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNDIQEKVINYSDTIDLADGNYVVRRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFTNFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDTKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SDKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKMQVAED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NTQNNLPPLKIYEAIGSGNRNLQAGNLCNNNIKAINYITGVDNPNAKSYLVVLLNKDKNY
YIRVPQTSPNIENQIKFKREEGDLRNLMNSSVNIIDNLNSTGAHYYTRQSPDVGNYISYE
FTVPGNFNNKDTSNIRLYTSNNQGIGTLFRVIETIDGYKLIGIRQNLHLLNNTNSIRLLN
GAIYILKVEVTELNNYNIRLHIDITD*
>PROKKA_00016 hypothetical protein
MCDKKYIIEFLIYLSIVILVIIISSEVCMYTFNFKQIIIRLI*
>PROKKA_00017 hypothetical protein
MKIKHPKVNEYYNYLKESFANVNLSEEHRMDIYKRIEIIEALVGLYEQKYEFDDEIIEDL
KLKYRPVFPEELKNIQKNLEKTIIK*
>PROKKA_00018 hypothetical protein
MDIPDIPEYLIETIFGNIDQRLKQNFYNFYENLFNMNNKEENLKLLIKDIIQKEFMVAEL
TKISDMDLHKTKHTFIAPDKINKLKRYNLQQIKQTKKRWYNSLFKKKKTNPFNIEIETAN
NNITLYGPEVFFNLYKVRSIEELKDIRAAQFKDWLDNSIFITDFFYLKSKTNKQINTAFN
LDFIYNICTIIYDKWNNNLNFIYMEYPKLLLDHPLVADGSGKIKVHKQTIIQQNQSNKDV
KYKYNDYVSKDGITRILVPESNIDTKQSRLIDNKDLNILSNILKYKKADFLTNKTIVFNL
IDIINNIYCSKTVRSYEDLRNRIAKMTLLKFNFFRTDNTSGIPDAVYGIFSSYEYLDKSQ
NRVKVYVDSILYDKILKNQVYTIYNDKINQLNDDFAKTLVIYLQQEKLVLYTQGKNTTFL
SYDYFSNLVRFRYKKEERNYKIIAQALENMKCNNIIIRDFKKHMNGFIITFLDTNQFEIS
DLFSNKNTSDILPMI*
>PROKKA_00019 hypothetical protein
MALAIEKLFFNVSKNLIHFITEPIPLYHYKTISFNKCCYCPFYKKMYDKNIHNYCSNYCN
NKYKKVIKKYNIYNNINIDKTHIQFSLTQIKQMLIYYYYANSKGFVSLISKKRIAKMIGC
CEKTVDINNKLFSDLGLILISGTINNKFSLIIKDYSEHYSKNNSGYLNLATNVFKDLLHI
NNVNALRIALQGILKHDINTLLDRETYFSINNMKTFLPDYINCKSAIEKIICRLNSNTIT
MLFNSSEKLIFIISKNLHGKLLKKEMYYKYKNNFLNYITENNIKLNNLSHSINNIVKLSF
EYGYDIVQLMLGEIKDIAPTIFNVGGYIRDKIKRYIYMNEPFFAI*
>PROKKA_00020 hypothetical protein
MEILYYVNNETNVLLVTTEEKDHMHYIKINKKDFLKYKKAGYAIITSAEMDFDLCLKMFS
PTFKEKIINIIKKAIRNEYIIAEKRTDNKYTISVIDSNFKLVL*
>PROKKA_00021 DNA-directed RNA polymerase subunit alpha
MILGGNKKMRKNKRDELRELNLSIRAYNSLRNMGINTLEDLSTYSKKQLYQFKGIGIVSL
RKIEKGLDKKNMKMEAV*
